Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Immunotherapy (Hagerstown, Md. : 1997)"
DOI: 10.1097/cji.0000000000000392
Abstract: Supplemental Digital Content is available in the text. Immunotherapy has revolutionized the treatment in metastatic melanoma, but alternative biomarkers that are economical, simple and reliable still need to be clarified. In this study, we aimed…
read more here.
Keywords:
patients receiving;
melanoma patients;
receiving immunotherapy;
melanoma ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "BMJ Open"
DOI: 10.1136/bmjopen-2019-035031
Abstract: Abstract Objectives To explore the relationship between the pretreatment or post-treatment neutrophil to lymphocyte ratio (NLR) and overall survival (OS)/progression-free survival (PFS) in patients with lung cancer receiving immunotherapy. Design We searched several databases to…
read more here.
Keywords:
pfs;
patients lung;
receiving immunotherapy;
cancer receiving ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-130911
Abstract: Abstract Introduction Immuno-oncology shows significant promise in the treatment of malignancy but is associated with a variety of immune-related adverse events. We previously reported that venous thromboembolism (VTE) occurred in over 20% of patients treated…
read more here.
Keywords:
receiving immunotherapy;
patients receiving;
mdsc;
cancer ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancer Management and Research"
DOI: 10.2147/cmar.s375821
Abstract: Purpose The present study assessed the effects of radiotherapy on overall survival (OS) and progression-free survival time (PFS) in patients with stage II or higher esophageal cancer receiving immunotherapy; evaluated factors independently prognostic of OS…
read more here.
Keywords:
esophageal cancer;
receiving immunotherapy;
months months;
propensity ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.962173
Abstract: Background It remains controversial whether the platelet to lymphocyte ratio (PLR) serves as a potential indicator for the efficacy of immunotherapy in advanced lung cancer. This meta-analysis aimed to address this concern. Methods Up to…
read more here.
Keywords:
lung cancer;
plr;
advanced lung;
receiving immunotherapy ... See more keywords